jimnyc
06-07-2020, 12:57 PM
People were talking about this medication as possible medication to save their lives should they have no alternative. Many changed their outlook - due to fake studies.
--
Surgisphere – The Firm Behind Two Retracted Hydroxychoroquine Studies – Claimed They Had Data on 150,000 COVID Patients But Couldn’t Prove 15,000 in Their Journal Report
Yesterday we learned that a second major medical journal retracted a study about hydroxychoroquine based on data supplied by US company Surgisphere.
Today we have even more about this company.
As was reported earlier the highly respected Lancet medical journal retracted a major study about hydroxychloroquine and then the New England Journal of Medicine has yanked another study.
Both studies relied on data supplied by a U.S. analytics company called Surgisphere.
The Guardian reported.
A peer-reviewed Lancet study claimed that Surgisphere culled data from nearly 15,000 COVID-19 patients from 1,200 hospitals around the world. There is no evidence that it collected any data from anyone.
The bogus study by Lancet, a British company, said the anti-malarial drugs hydroxychloroquine and chloroquine, both of which have been touted by President Trump as a coronavirus treatment, were not only ineffective but possible deadly. Lancet said in the May 22 study that patients who used those drugs were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and were more likely to die in the hospital.
Rest - https://www.thegatewaypundit.com/2020/06/surgisphere-firm-behind-two-retracted-hydroxychoroquine-studies-claimed-data-150000-covid-patients-couldnt-prove-15000-journal-report/
--
Surgisphere – The Firm Behind Two Retracted Hydroxychoroquine Studies – Claimed They Had Data on 150,000 COVID Patients But Couldn’t Prove 15,000 in Their Journal Report
Yesterday we learned that a second major medical journal retracted a study about hydroxychoroquine based on data supplied by US company Surgisphere.
Today we have even more about this company.
As was reported earlier the highly respected Lancet medical journal retracted a major study about hydroxychloroquine and then the New England Journal of Medicine has yanked another study.
Both studies relied on data supplied by a U.S. analytics company called Surgisphere.
The Guardian reported.
A peer-reviewed Lancet study claimed that Surgisphere culled data from nearly 15,000 COVID-19 patients from 1,200 hospitals around the world. There is no evidence that it collected any data from anyone.
The bogus study by Lancet, a British company, said the anti-malarial drugs hydroxychloroquine and chloroquine, both of which have been touted by President Trump as a coronavirus treatment, were not only ineffective but possible deadly. Lancet said in the May 22 study that patients who used those drugs were more likely to show an irregular heart rhythm—a known side effect thought to be rare—and were more likely to die in the hospital.
Rest - https://www.thegatewaypundit.com/2020/06/surgisphere-firm-behind-two-retracted-hydroxychoroquine-studies-claimed-data-150000-covid-patients-couldnt-prove-15000-journal-report/